» Articles » PMID: 28108359

Synaptic Targets: Chronic Alcohol Actions

Overview
Specialties Neurology
Pharmacology
Date 2017 Jan 22
PMID 28108359
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol acts on numerous cellular and molecular targets to regulate neuronal communication within the brain. Chronic alcohol exposure and acute withdrawal generate prominent neuroadaptations at synapses, including compensatory effects on the expression, localization and function of synaptic proteins, channels and receptors. The present article reviews the literature describing the synaptic effects of chronic alcohol exposure and their relevance for synaptic transmission in the central nervous system. This review is not meant to be comprehensive, but rather to highlight the effects that have been observed most consistently and that are thought to contribute to the development of alcohol dependence and the negative aspects of withdrawal. Specifically, we will focus on the major excitatory and inhibitory neurotransmitters in the brain, glutamate and GABA, respectively, and how their neuroadaptations after chronic alcohol exposure contributes to alcohol reinforcement, dependence and withdrawal. This article is part of the Special Issue entitled "Alcoholism".

Citing Articles

Biochemical changes precede affective and cognitive anomalies in aging adult C57BL/6J mice with a prior history of adolescent alcohol binge-drinking.

Chavez C, Scheldrup G, Madory L, Denning C, Lee E, Nguyen D Addict Biol. 2024; 29(12):e70006.

PMID: 39665499 PMC: 11635696. DOI: 10.1111/adb.70006.


Chronic ethanol exposure in mice evokes pre- and postsynaptic deficits in GABAergic transmission in ventral tegmental area GABA neurons.

Mitten E, Souders A, Marron Fernandez de Velasco E, Aguado C, Lujan R, Wickman K Br J Pharmacol. 2024; 182(1):69-86.

PMID: 39358985 PMC: 11831720. DOI: 10.1111/bph.17335.


Withdrawal from chronic alcohol impairs the serotonin-mediated modulation of GABAergic transmission in the infralimbic cortex in male rats.

Vlkolinsky R, Khom S, Vozella V, Bajo M, Roberto M Neurobiol Dis. 2024; 199:106590.

PMID: 38996987 PMC: 11412312. DOI: 10.1016/j.nbd.2024.106590.


Potential Link Between Exercise and N-Methyl-D-Aspartate Glutamate Receptors in Alcohol Use Disorder: Implications for Therapeutic Strategies.

Sedhom S, Hammond N, Thanos K, Blum K, Elman I, Bowirrat A Psychol Res Behav Manag. 2024; 17:2363-2376.

PMID: 38895648 PMC: 11185169. DOI: 10.2147/PRBM.S462403.


Abstinence and Fear Experienced during This Period Produce Distinct Cortical and Hippocampal Adaptations in Alcohol-Dependent Rats.

Steiner N, Purohit D, Tiefenthaler C, Mandyam C Brain Sci. 2024; 14(5).

PMID: 38790410 PMC: 11118749. DOI: 10.3390/brainsci14050431.


References
1.
Anderson N, Daunais J, Friedman D, Grant K, McCool B . Long-term ethanol self-administration by the nonhuman primate, Macaca fascicularis, decreases the benzodiazepine sensitivity of amygdala GABA(A) receptors. Alcohol Clin Exp Res. 2007; 31(6):1061-70. PMC: 2288551. DOI: 10.1111/j.1530-0277.2007.00394.x. View

2.
Roberto M, Cruz M, Gilpin N, Sabino V, Schweitzer P, Bajo M . Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence. Biol Psychiatry. 2010; 67(9):831-9. PMC: 2883449. DOI: 10.1016/j.biopsych.2009.11.007. View

3.
McCool B, Frye G, Pulido M, Botting S . Effects of chronic ethanol consumption on rat GABA(A) and strychnine-sensitive glycine receptors expressed by lateral/basolateral amygdala neurons. Brain Res. 2003; 963(1-2):165-77. PMC: 2925189. DOI: 10.1016/s0006-8993(02)03966-5. View

4.
Iorio K, Tabakoff B, Hoffman P . Glutamate-induced neurotoxicity is increased in cerebellar granule cells exposed chronically to ethanol. Eur J Pharmacol. 1993; 248(2):209-12. DOI: 10.1016/0926-6917(93)90045-r. View

5.
Christian D, Alexander N, Diaz M, Robinson S, McCool B . Chronic intermittent ethanol and withdrawal differentially modulate basolateral amygdala AMPA-type glutamate receptor function and trafficking. Neuropharmacology. 2012; 62(7):2430-9. PMC: 3314101. DOI: 10.1016/j.neuropharm.2012.02.017. View